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Occurrence of an Eledoisin-Like Polypeptide 
(Physalaemin) in Skin Extracts of 
Physalaemus fuscumaculatus1
Acetone and methanol extracts of wet or dry skin of 
Physalaemus fuscumaculatus, a South-American amphib­
ian (Tucuman, Argentine), contain a principle which 
exerts a powerful stimulant action on several smooth­
muscle preparations and potently lowers the systemic 
blood pressure in dogs and rabbits.
The active principle, which we call physalaemin, is in 
all probability a polypeptide. In fact, it was completely 
inactivated both by chymotrypsin and trypsin digestion 
(extract corresponding to 0.1 g fresh skin plus 100 ug 
chymotrypsin or 1 mg trypsin; incubation for 30 min at 
pH 7.5-7.7 and 38°C), and acid hydrolysis of active 
chromatographic spots yielded a mixture of amino acids.
Physalaemin may be distinguished in parallel assays 
from all other known polypeptides, including eledoisin2. 
However, eledoisin is the polypeptide to which physalae­
min seems so far to be most similar in its pharmacological 
properties.
Like eledoisin, physalaemin potently stimulates move­
ments and tonus of the isolated rabbit large intestine 
(threshold concentration : extract corresponding to 1-2 fig 
fresh tissue per ml nutrient liquid), the isolated guinea-pig 
ileum (2-6 /zg fresh tissue/ml), and other preparations of 
gastro-intestinal smooth muscle as well (rat stomach, rat 
duodenum, frog stomach, etc.) ; like eledoisin, physalae­
min is not very active on the oestrus uterus of the rat.
The blood pressure of the anaesthetized dog and rabbit 
is potently lowered by the intravenous injection of 
Physalaemus extracts. Intensity and duration of hypo­
tension are proportional to the injected dose of physalae­
min and there is no sign of tachyphylaxis. A short-lived 
but evident fall of blood pressure may be produced in 
the dog by the intravenous injection of the extract 
corresponding to 5 fig fresh skin per kg body weight.
The accompanying Table gives some approximate 
activity equivalencies for the extract corresponding to 1 g 
fresh Physalaemus skin.
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Approximate equivalencies for 1 g fresh Physalae­
mus skin
Elcdoisin Substance P Bradykinin Disfamili
Dog blood 300-400 (xg 20000 to >20 mg > 20 mg
pressure 30000 fi
Rabbit large 150-200 pLg 50000 fi >15 mg > 100 mg
intestine
Rat uterus 30-50 pig 50-200 fl < 1 [Xg inhibition
Rat duodenum 100 (xg - - inhibition —
Guinea-pig ileum 100-200 pig 0.5-2 mg —
Rabbit large intestine, guinea-pig ileum and dog or 
rabbit blood pressure are particularly suitable for the 
quantitative bioassay of physalaemin, owing to their 
high sensitivity and the excellent dose/response relation­
ship.
Crude Physalaemus extracts do not apparently contain 
other active substances with the possible exception of 
small amounts of a bradykinin-like polypeptide. A 
biologically pure physalaemin preparation may be 
obtained by absorption of the crude Physalaemus 
material dissolved in 95% ethanol on an alkaline alumina 
column and subsequent elution with descending concen­
trations of ethanol, followed by ion-exchange chromato­
graphy on a column of Amberlite CG-50.
The occurrence of physalaemin is now being investi­
gated in other Physalaemus species, as well as in numerous 
other amphibians gathered throughout the world.
A full report on the pharmacological properties of 
physalaemin will be published elsewhere. The isolation 
of the polypeptide and the elucidation of its structure is 
in progress.
Riassunto. Gli estratti di pelle fresca o secca di 
Physalaemus fuscumaculatus contengono una sostanza 
attiva di natura polipeptidica, la physalaemina, dotata di 
potente azione ipotensiva e di intensa azione stimolante 
su alcuni muscoli lisci extravasali. La physalaemina è 
facilmente distinguibile, mediante saggi paralleli, da 
tutti gli altri polipeptidi biogeni finora noti, compresa la 
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eledoisina che alla physalaemina s’accosta per parecchie 
delle sue azioni farmacologiche.
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